Enzo Biochem Inc ENZ:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:39 AM EDT
3.25quote price arrow up+0.09 (+2.85%)
Volume
21,552
Close
3.16quote price arrow down-0.09 (-2.77%)
Volume
471,009
52 week range
1.80 - 4.85

...

Loading . . .
  • Open3.17
  • Day High3.23
  • Day Low3.05
  • Prev Close3.16
  • 52 Week High4.85
  • 52 Week High Date03/16/21
  • 52 Week Low1.80
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap152.41M
  • Shares Out48.23M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.93
  • YTD % Change25.4

KEY STATS

  • Open3.17
  • Day High3.23
  • Day Low3.05
  • Prev Close3.16
  • 52 Week High4.85
  • 52 Week High Date03/16/21
  • 52 Week Low1.80
  • 52 Week Low Date11/02/20
  • Market Cap152.41M
  • Shares Out48.23M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.93
  • YTD % Change25.4

RATIOS/PROFITABILITY

  • EPS (TTM)-0.22
  • P/E (TTM)-14.25
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-3.402M
  • ROE (MRQ)-15.96%
  • Revenue (MRQ)96.55M
  • Gross Margin (MRQ)41.42%
  • Net Margin (MRQ)-10.96%
  • Debt To Equity (MRQ)18.85%

EVENTS

  • Earnings Date06/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Enzo Biochem Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. It offers a menu of molecular and other clinical laboratory tests or...
Barry Weiner
President
David Bench
Chief Financial Officer
Address
60 EXECUTIVE BLVD
Farmingdale, NY
11735
United States

Top Peers

SYMBOLLASTCHG%CHG
HBIO
Harvard Bioscience Inc
6.71-0.12-1.76%
ADMS
Adamas Pharmaceuticals Inc
5.16-0.14-2.64%
CTMX
CytomX Therapeutics Inc
7.96+0.36+4.74%
PLX
Protalix Biotherapeutics Inc
5.50-0.45-7.56%
SURF
Surface Oncology Inc
6.45-0.11-1.68%
VSTM
Verastem Inc
2.71+0.01+0.37%